Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Allograft Fibrosis Following Pediatric Cardiac Transplantation

This study has been terminated.
(unable to gather sufficient data)
Information provided by:
Children's Healthcare of Atlanta Identifier:
First received: May 18, 2006
Last updated: March 14, 2012
Last verified: January 2006
Transplantation is the preferred method of treating many forms of end-stage organ failure. While short-term results have improved, long-term outcomes remain inadequate. Myocardial fibrosis could potentially have an adverse effect on long-term cardiac function. We wish to study the degree of fibrosis to see if we can predict survival following pediatric heart transplantation.

Children Who Underwent Heart Transplantation Prior to Age 18
Received Care at Children's Healthcare of Atlanta

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Allograft Fibrosis: Its Regulation and Significance Following Pediatric Cardiac Transplantation

Resource links provided by NLM:

Further study details as provided by Children's Healthcare of Atlanta:

Enrollment: 100
Study Start Date: January 2006
Study Completion Date: December 2006
  Show Detailed Description


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Children who underwent heart transplantation prior to age 18

Inclusion Criteria:

  • Children who underwent heart transplantation prior to age 18
  • Followed up at Children's Healthcare of Atlanta

Exclusion Criteria:

  • Children without a transplanted heart
  • Follow-up not at children's Healthcare of Atlanta
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00328185

United States, Georgia
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30329
Sponsors and Collaborators
Children's Healthcare of Atlanta
Principal Investigator: Brian E Kogon, MD Emory University
  More Information Identifier: NCT00328185     History of Changes
Other Study ID Numbers: 05-217
Study First Received: May 18, 2006
Last Updated: March 14, 2012

Keywords provided by Children's Healthcare of Atlanta:
heart disease
orthotopic heart transplantation
allograft fibrosis

Additional relevant MeSH terms:
Pathologic Processes processed this record on April 26, 2017